Clinical Trial Update: Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 1/2 clinical trial evaluating intralymphatic immunotherapy with Polvac grass and rye allergen extract for allergic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Polvac Grass & Rye Allergen Extract (Grass and rye pollen allergen extract)

Snippet

Sponsor: University of Zurich | Conditions: Rhinitis, Allergic, Seasonal, Rhinitis; Allergic, With Asthma | Phase 1, Phase 2 | Status: COMPLETED